Breaking News Instant updates and real-time market news.

BCS

Barclays

$7.41

0.385 (5.48%)

, BK

BNY Mellon

$43.49

0.67 (1.56%)

04:55
10/11/19
10/11
04:55
10/11/19
04:55

Asia Securities Industry & Financial Markets Association holds a conference

ASIFMA Annual Conference 2019 will be held in Tokyo, Japan on October 10-11.

BCS

Barclays

$7.41

0.385 (5.48%)

BK

BNY Mellon

$43.49

0.67 (1.56%)

BNPQY

BNP Paribas

$0.00

(0.00%)

C

Citi

$68.63

1.18 (1.75%)

CS

Credit Suisse

$11.62

0.195 (1.71%)

GOOG

Alphabet

$1,207.98

6.59 (0.55%)

GS

Goldman Sachs

$199.85

3.02 (1.53%)

HSBC

HSBC

$36.90

0.97 (2.70%)

INFO

IHS Markit

$67.96

0.32 (0.47%)

JPM

JPMorgan

$114.24

1.58 (1.40%)

MCO

Moody's

$211.13

1.7 (0.81%)

MFC

Manulife Financial

$17.64

0.19 (1.09%)

MUFG

Mitsubishi UFJ

$4.96

0.025 (0.51%)

NMR

Nomura

$4.36

0.045 (1.04%)

SCBFF

Standard Chartered

$0.00

(0.00%)

SCGLY

Societe Generale

$0.00

(0.00%)

TW

Tradeweb Markets

$41.01

1.2 (3.01%)

UBS

UBS

$10.78

0.2 (1.89%)

  • 11

    Oct

  • 11

    Oct

  • 11

    Oct

  • 11

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 18

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 07

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

BCS Barclays
$7.41

0.385 (5.48%)

08/21/19
EXAN
08/21/19
UPGRADE
EXAN
Neutral
Barclays upgraded to Neutral from Underperform at Exane BNP Paribas
Exane BNP Paribas analyst Guy Stebblings upgraded Barclays to Neutral citing less material downside in US card growth and UK NIM expectations.
11/09/18
FBCO
11/09/18
DOWNGRADE
FBCO
Neutral
Barclays downgraded to Neutral from Outperform at Credit Suisse
09/05/19
KBWI
09/05/19
UPGRADE
KBWI
Market Perform
Barclays upgraded to Market Perform from Underperform at Keefe Bruyette
BK BNY Mellon
$43.49

0.67 (1.56%)

07/18/19
KBWI
07/18/19
UPGRADE
Target $47
KBWI
Market Perform
BNY Mellon upgraded to Market Perform from Underperform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl upgraded BNY Mellon to Market Perform from Underperform and raised his price target for the shares to $47 from $46. Following the company's Q2 results, the analyst feels its negative catalysts are slowly reversing.
07/18/19
07/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Apple (AAPL) and Skyworks (SWKS) upgraded to Outperform from Market Perform at Raymond James with analyst Christopher Caso citing greater confidence in next year's 5G iPhone cycle. 2. PriceSmart (PSMT) upgraded to Outperform from Sector Perform at Scotiabank. 3. BNY Mellon (BK) upgraded to Market Perform from Underperform at Keefe Bruyette with analyst Brian Kleinhanzl saying after the company's Q2 results, he feels its negative catalysts are slowly reversing. 4. U.S. Bancorp (USB) upgraded to Neutral from Underperform at BofA/Merrill with analyst Erika Najarian saying she believes earnings headwinds have reached an inflection point and net interest margin is more defensible versus peers. 5. Power Integrations (POWI) upgraded to Buy from Hold at Stifel with analyst Tore Svanberg citing the company's near-term momentum from the USB-PD adoption cycle as well as its longer-term opportunity in the high-power industry and auto. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/08/19
07/08/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Sell from Neutral at Rosenblatt with analyst Jun Zhang citing his view that its fundamental will deteriorate over the next 6-12 months. 2. Verizon (VZ) downgraded to Neutral from Buy at Citi with analyst Michael Rollins saying rising long-term industry risks and the stock's current valuation premium are likely to limit returns over the next 12-months. 3. F5 Networks (FFIV) downgraded to Sell from Neutral at Goldman Sachs with analyst Rod Hall saying the company's earnings risks are increasing due to the weaker short-term spending environment and increasing competitive threat. 4. BNY Mellon (BK) and State Street (STT) were double downgraded to Underweight from Overweight at Morgan Stanley. 5. American Airlines (AAL) downgraded to Underperform from Neutral at Credit Suisse with analyst Jose Caiado citing labor and Boeing (BA) 737 Max risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/02/19
WOLF
10/02/19
UPGRADE
Target $50
WOLF
Peer Perform
BNY Mellon upgraded to Peer Perform from Underperform at Wolfe Research
Wolfe Research analyst Steven Chubak upgraded BNY Mellon to Peer Perform from Underperform following a period of underperformance in the stock as "deep cuts" were being made to 2020 consensus forecasts. However, the bank's deposits are strongly correlated to Fed balance sheet assets and excess reserves and he expects net interest income headwinds to abate as the central bank is poised for balance sheet expansion, Chubak tells investors. He raised his price target on BNY Mellon shares to $50 from $45.
BNPQY BNP Paribas
$0.00

(0.00%)

09/09/19
SOCG
09/09/19
DOWNGRADE
SOCG
Sell
BNP Paribas downgraded to Sell from Hold at Societe Generale
Societe Generale analyst Geoffrey Dawes downgraded BNP Paribas to Sell from Hold.
04/03/19
BOFA
04/03/19
INITIATION
BOFA
Neutral
BNP Paribas reinstated with a Neutral at BofA/Merrill
BofA/Merrill reinstated coverage of BNP Paribas with an Neutral rating. The firm has a cautious view on French banks saying the need to build up capital will take many years and that 2020 targets are "uninspiring."
09/13/19
MSCO
09/13/19
DOWNGRADE
MSCO
Equal Weight
BNP Paribas downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Bruce Hamilton downgraded BNP Paribas to Equal Weight from Overweight with a price target of 50 euros, down from 57.60 euros. The analyst sees declining profitability and a tight capital path.
C Citi
$68.63

1.18 (1.75%)

09/24/19
MSCO
09/24/19
NO CHANGE
MSCO
Large-cap banks aren't gaining deposit market share, says Morgan Stanley
Morgan Stanley analyst Ken Zerbe said he continues to hear the "false narrative" that large-cap banks must be gaining market share due to their superior technology, but he insists they are not and that small and mid-cap banks have consistently gained deposit market share over the last five years. Individual large-cap banks that have had the biggest deposit share gains include Goldman Sachs (GS), Ally Financial (ALLY) and Synchrony Financial (SYF), while mid-cap banks that have delivered the biggest gains in share of total deposits include First Republic (FRC), KeyCorp (KEY) and Huntington (HBAN), Zerbe tells investors. Large-cap banks that have seen the largest declines in their respective individual shares of total deposits include JPMorgan (JPM), Wells Fargo (WFC) and Citigroup (C), while deposit share losers among mid-cap banks include Comerica (CMA), Prosperity Bancshares (PB) and Zions (ZION), said Zerbe.
09/10/19
UBSW
09/10/19
DOWNGRADE
Target $49
UBSW
Neutral
Wells Fargo downgraded to Neutral from Buy at UBS
UBS analyst Saul Martinez downgraded Wells Fargo (WFC) to Neutral and lowered his price target on the stock to $49 from $51. The analyst attributes the rating change to his reduced estimates for earnings and lower net interest income along with the continued uncertainty and low visibility around the progress in the management's efficiency improvements. Martinez also cites Wells Fargo's relative valuation, with shares trading at 11.3-times expected FY20 earnings - a premium to JP Morgan's (JPM) 10.8-times, Bank of America's (BAC) 9.2-times, and Citigroup's (C) 7.9-times.
09/06/19
BOFA
09/06/19
NO CHANGE
BOFA
BofA/Merrill sees Citi, Citizens BB&T risk/reward as 'compelling'
BofA Merrill Lynch analyst Erika Najarian said she does not believe bank stocks are pricing in a recession, though they are "bearing the brunt of cycle concerns." Bank stocks could be at a near-term bottom, said Najarian, who sees compelling risk/rewards for shares of Citi (C), Citizens Financial (CFG) and BB&T (BBT) even when taking into account theoretical fair value in a recession. Even in the case of a recession, banks have materially improved underwriting since the financial crisis and she estimates an average 46% EPS hit in a downturn but only a 5% hit in tangible book value versus consensus 2020 forecasts, Najarian tells investors.
07/26/19
07/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Goldman Sachs (GS) and Citi (C) upgraded to Outperform from Market Perform at Keefe Bruyette. 2. Ambev (ABEV) upgraded to Neutral from Underweight at JPMorgan with analyst Lucas Ferreira saying the post-earnings share rally shows that investors are chasing good growth stories to play Brazil's economic recovery. 3. West Pharmaceutical (WST) upgraded to Neutral from Underperform at BofA/Merrill with analyst Derik de Bruin saying that over the course of the first half, the company addressed his prior concerns around organic revenue growth and product mix trends while also boosting its operating margins and generating higher free cash flows. 4. Union Pacific (UNP) upgraded to Overweight from Neutral at Atlantic Equities, while CSX (CSX) was upgraded to Neutral from Underweight. 5. Hasbro (HAS) upgraded to Buy from Hold at Argus with analyst John Staszak citing the company's dominant position with a range of "strong" brands as well as in the big-screen business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CS Credit Suisse
$11.62

0.195 (1.71%)

08/30/19
08/30/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Abercrombie & Fitch (ANF) upgraded to Hold from Sell at Deutsche Bank with analyst Tiffany saying the company's falling margins are now reflected in its guidance. 2. DuPont (DD) upgraded to Outperform from Neutral at Exane BNP Paribas. 3. Credit Suisse (CS) upgraded to Outperform from Neutral at Exane BNP Paribas. 4. Tabula Rasa HealthCare (TRHC) upgraded to Buy from Hold at Stifel with analyst David Grossman saying the shares are trading at 4.1 times estimated 2020 revenue, which is more in line with comparable companies and a more attractive entry point, particularly given potential catalysts over the next 12-18 months. 5. CAE (CAE) upgraded to Outperform from Sector Perform at Scotiabank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/30/19
EXAN
08/30/19
UPGRADE
EXAN
Outperform
Credit Suisse upgraded to Outperform from Neutral at Exane BNP Paribas
Exane BNP Paribas analyst Jeremy Sigee upgraded Credit Suisse to Outperform from Neutral and raised his price target for the shares to 14.20 francs from 13 francs.
03/13/19
JPMS
03/13/19
DOWNGRADE
JPMS
Neutral
Credit Suisse downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Kian Abouhossein downgraded Credit Suisse to Neutral from Overweight and lowered his price target for the shares to 14 francs from 16 francs. The company's investment banking strategy is "value destroying," Abouhossein tells investors in a research note. Further, he believes Credit Suisse's cost cuts are fully discounted in the current valuation.
03/13/19
03/13/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Roku (ROKU) downgraded to Sell from Hold at Loop Capital and to Neutral from Outperform at Macquarie. 2. Hercules Capital (HTGC) downgraded to Market Perform from Outperform at Keefe Bruyette and to Neutral from Buy at Compass Point as well as B. Riley FBR. 3. Credit Suisse (CS) downgraded to Neutral from Overweight at JPMorgan with analyst Kian Abouhossein saying the company's investment banking strategy is "value destroying." 4. Comerica (CMA) downgraded to Neutral from Outperform at Wedbush with analyst Peter Winter saying he believes earnings growth will be more challenging in 2020 given less earnings levers, the benefit from lower expenses is behind, and share buyback activity is set to slow in 2020. 5. NuStar Energy (NS) downgraded to Underweight from Neutral at JPMorgan analyst Jeremy Tonet saying he sees lower return potential following the stock's "significant outperformance" year-to-date. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GOOG Alphabet
$1,207.98

6.59 (0.55%)

10/01/19
NEED
10/01/19
NO CHANGE
Target $11
NEED
Buy
Angi Homeservices price target lowered to $11 from $13 at Needham
Needham analyst Brad Erickson lowered his price target on Angi Homeservices to $11, saying the company's Nextdoor traffic deal looks like a "band-aid" amid "bleeding sentiment" and indications of more competitive pressure from Google (GOOGL) in the home services vertical. The analyst also lowers his FY20 EBITDA view to $251.6M from $258M on expectation of higher projected traffic spending, but keeps his Buy rating on the stock to reflect the continued strong monetization of HomeAdvisor.
10/08/19
PIPR
10/08/19
NO CHANGE
Target $440
PIPR
Overweight
Netflix loses lead to YouTube in Piper Jaffray teen survey
Piper Jaffray asked 9,500 high school students what percentage of their video consumption time they spend watching Netflix (NFLX), cable TV, Alphabet's (GOOG, GOOGL) YouTube and other over-the-top platforms, analyst Michael Olson tells investors in a research note. Netflix dipped slightly to 35% from 37% in Piper's last survey, ceding its multi-year pole position to YouTube, which leap-frogged to the top with 37%, up from 32% in the spring survey, says Olson. However, he believes Netflix continues to maintain "strong teen mind share" and attributes the position switch with YouTube at least partially to core differences between the content. Overall, fewer teens are indicating that their household subscribes to cable/satellite TV, which lost the most share, down to 12% versus 14% prior, the analyst points out. Olson maintains an Overweight rating on Netflix with a $440 price target.
10/08/19
OPCO
10/08/19
NO CHANGE
Target $410
OPCO
Outperform
Oppenheimer cautiously in line with consensus estimates, guidance for Netflix
After looking at 3P data from SimilarWeb, Google (GOOGL) Search Trends and YouTube Trailer views, Oppenheimer analyst Jason Helfstein notes that data points to mixed results for Netflix (NFLX). While SimilarWeb data suggests a Q3 subscriber miss, Google Trends and YouTube data are more favorable, he adds. Overall, the analyst believes the Street estimates have remained in line with guidance as uncertainty over data interpretation has led to an overhang, and says he remains cautiously in line with consensus estimates and guidance. Helfstein has an Outperform rating and $410 price target on Netflix shares.
10/03/19
DBAB
10/03/19
NO CHANGE
Target $1600
DBAB
Buy
Alphabet price target raised to Street-high $1,600 from $1,475 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for Alphabet (GOOG) to $1,600 from $1,475 and keeps a Buy rating on the name. The new target is the highest among sell-side analysts, according to Bloomberg. Shares of Alphabet closed Wednesday at $1,176.63. The "inflection" in Google Cloud under CEO Thomas Kurian, combined with improving disclosures, "helps bolster the bull thesis" around Alphabet shares, Walmsley tells investors in a research note. He thinks Google Cloud can compound revenue at 55% between 2018 and 2022, reaching $17B. Further, Google Cloud can contribute an estimated 7% to EBIT in 2022, says Walmsley.
GS Goldman Sachs
$199.85

3.02 (1.53%)

10/02/19
ODEN
10/02/19
NO CHANGE
ODEN
Hold
Goldman Sachs 'quite likely' to beat Q3 earnings consensus, says Odeon Capital
Odeon Capital analyst Richard Bove pointed out three reasons that he believes it is "quite likely" that Goldman Sachs will top the Q3 consensus EPS forecast of $5.41. The bank was ranked by Bloomberg as number one in U.S. equity offerings in the quarter, trading activity is likely to be higher on both a sequential and year-over-year basis and Goldman "typically" starts the process of lowering estimated compensation expenses in Q3, said Bove. Bove keeps a Hold rating on Goldman Sachs shares, noting that he thinks Goldman is unlikely to match its Q3 results in Q4.
09/05/19
ODEN
09/05/19
DOWNGRADE
ODEN
Hold
Goldman Sachs downgraded to Hold from Buy at Odeon Capital
Odeon Capital analyst Richard Bove downgraded Goldman Sachs to Hold from Buy, stating that he respects CEO David Solomon for moving aggressively to fix the bank's problems, but "the task is sizable and apparently it will take more time and more effort to put the company on a sounder course."
HSBC HSBC
$36.90

0.97 (2.70%)

06/21/19
MSCO
06/21/19
DOWNGRADE
MSCO
Equal Weight
HSBC cut to Equal Weight on rate and virtual bank pressures at Morgan Stanley
As previously reported, Morgan Stanley analysts led by Anil Agarwal and Magdalena Stoklosa downgraded HSBC to Equal Weight from Overweight and cut the price target on the London-listed shares to 690p from 740p. A recent pickup in HIBOR rates should help Q2 NIMs expand meaningfully for Hong Kong banks and elevated HIBOR levels could also translate into strong NIMs in Q3, unless HIBOR retraces quickly, the team said. However, they assume two Fed rate cuts by end-2020 and think lower NIMs due to lower Fed rates, as well as the launch of virtual banks, will hurt profitability, Agarwal and Stoklosa told investors in a research note on the Hong Kong financial group. The HKMA has licensed eight virtual banks, and these, particularly the ones backed by Chinese technology players, "are likely to compete fiercely," the analysts added.
10/09/19
MSCO
10/09/19
DOWNGRADE
MSCO
Underweight
HSBC downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Magdalena Stoklosa downgraded HSBC to Underweight from Equal Weight with a price target of 540 pence. The analyst views the valuation as rich given the slowing economy in Hong Kong.
07/24/19
JEFF
07/24/19
DOWNGRADE
JEFF
Hold
HSBC downgraded to Hold from Buy at Jefferies
Jefferies analyst Joseph Dickerson downgraded HSBC to Hold from Buy and lowered his price target for the shares to 6.91 pounds from 8.50 pounds. The bank needs a "new narrative" as recent short-term interest rate rises have not translated into margin improvements, Dickerson tells investors in a research note.
08/06/19
FBCO
08/06/19
NO CHANGE
Target $680
FBCO
Neutral
HSBC price target raised to $680 from $670 at Credit Suisse
Credit Suisse analyst Jon Peace raised his for HSBC to $680 from $670 following quarterly results. While the analyst notes that Q2 results were a little ahead of expectations on key P&L lines, a more cautious outlook relating to rates and U.S. profitability leads him to leave his forecasts largely unchanged. Peace reiterates a Neutral rating on the shares.
INFO IHS Markit
$67.96

0.32 (0.47%)

06/27/19
PIPR
06/27/19
NO CHANGE
Target $70
PIPR
Overweight
IHS Markit price target raised to $70 from $64 at Piper Jaffray
Piper Jaffray analyst Peter Appert raised his price target for IHS Markit to $70 from $64 and keeps an Overweight rating on the shares. The catalysts for the stock are improving organic revenue growth, margin upside and leverage from free cash flow, all of which can happen over the next 12-18 months, Appert tells investors in a research note. The analyst says IHS Markit's "solid" fiscal Q2 revenue and earnings beat reinforces his confidence in the "secular growth story."
06/28/19
DBAB
06/28/19
NO CHANGE
Target $70
DBAB
Buy
IHS Markit price target raised to $70 from $63 at Deutsche Bank
Deutsche Bank analyst Ashish Sabadra raised his price target for IHS Markit to $70 from $63 and keeps a Buy rating on the shares following meetings with management. Management highlighted their focus on accretive growth areas with large total addressable markets and a focus on new production innovation leveraging Data Lake, Sabadra tells investors in a research note. The analyst says the meetings reinforce confidence in the company's 5%-7% revenue growth.
06/27/19
CANT
06/27/19
NO CHANGE
Target $59
CANT
Neutral
IHS Markit price target raised to $59 from $51 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi raised his price target for IHS Markit to $59 from $51 while keeping a Neutral rating on the shares following the company's Q2 results. The analyst likes IHS Markit's opportunities in transportation and financial services, but awaits better visibility on the outlook for oil capex, margins, and color on the transactional businesses.
06/27/19
RHCO
06/27/19
NO CHANGE
Target $70
RHCO
Buy
IHS Markit price target raised to $70 from $62 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target for IHS Markit to $70 from $62 and maintained a Buy rating, telling investors in a research note that he is confident IHS can deliver at least mid-single percentage through-the-cycle organic revenue growth and drive EBITDA margin toward the mid-40s. Jeffrey says he is "particularly encouraged" by Transportation, where he feels high-single percentage organic revenue growth is more durable than the consensus view.
JPM JPMorgan
$114.24

1.58 (1.40%)

09/16/19
09/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Halliburton (HAL) downgraded to Equal Weight from Overweight at Barclays with analyst J. David Anderson saying he sees "only modest upside" to the shares after revising his estimates lower. 2. Aurora Cannabis (ACB) downgraded to Sell from Hold at Stifel with analyst W. Andrew Carter saying he sees "meaningful downside" from current share levels following the company's "disappointing" Q4 earnings release. 3. HP Inc. (HPQ) downgraded to Neutral from Buy at UBS with analyst John Roy saying he points to downside risk for the company's flat expectations in its printing supplies business amid low visibility and uncertain macro backdrop. Roy further believes that HP's PC margin would decline by more than consensus as the company passes through the component price declines and the sales mix shift away from commercial. 4. Dick's Sporting (DKS) downgraded to Market Perform from Outperform at Wells Fargo with analyst Tom Nikic saying now that Dick's has returned to positive comps and the stock has re-rated, the risk/reward is more evenly balanced. 5. JPMorgan (JPM) downgraded to Neutral from Buy at Buckingham with analyst James Mitchell citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/16/19
BUCK
09/16/19
DOWNGRADE
BUCK
Neutral
JPMorgan downgraded to Neutral from Buy at Buckingham
09/16/19
BUCK
09/16/19
DOWNGRADE
Target $122
BUCK
Neutral
Buckingham downgrades 'great company' JPMorgan to Neutral on valuation
As previously reported, Buckingham analyst James Mitchell downgraded JPMorgan to Neutral from Buy, calling it a "great company" whose shares have become fairly valued and now trade at nearly a 30% premium on a P/E basis to its peer group. He stills views JPMorgan as an attractive story for long-term holders and believes its "best-in-class" top line growth and returns can continue. Mitchell has a $122 price target on JPMorgan shares.
MCO Moody's
$211.13

1.7 (0.81%)

10/07/19
UBSW
10/07/19
UPGRADE
Target $245
UBSW
Buy
Moody's upgraded to Buy from Neutral at UBS
UBS analyst Alex Kramm upgraded Moody's to Buy from Neutral with a price target of $245, up from $215. Following two years of "lackluster" performance, the "ingredients are in place for corporate issuance to meaningfully improve," Kramm tells investors in a research note. The analyst expects the combination of low interest rates, easier compares, and "significant" corporate debt refinancing needs to drive nearly 9% ratings growth in 2020 versus the 5%-6% consensus expectations. With Moody's shares nearly 10% off their recent highs, the analyst sees an attractive entry point at current levels.
08/05/19
ARGS
08/05/19
NO CHANGE
Target $240
ARGS
Buy
Moody's price target raised to $240 from $205 at Argus
Argus analyst John Eade raised his price target on Moody's to $240 and kept his Buy rating after its Q2 earnings beat, saying that while the stock has outperformed the S&P500 index over the past quarter, he sees "more value" in the shares. The analyst notes that Moody's is facing risks around defaults in the corporate bond market and a slowdown in corporate debt issuance, but he also expects the company to benefit from the secular trends of "global GDP growth and debt market disintermediation" over the longer term.
10/07/19
10/07/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Match Group (MTCH) upgraded to Buy from Neutral at Nomura Instinet and to Buy from Hold at Deutsche Bank. 2. Uber (UBER) upgraded to Buy from Neutral at Citi with analyst Itay Michaeli saying the company's upcoming Q3 results should bring an acceleration in revenue growth and swing investment sentiment more favorably. 3. Arconic (ARNC) upgraded to Overweight from Neutral at JPMorgan with analyst Seth Seifman saying he sees a "compelling" risk/reward profile following the stock's 8% decline in the past two weeks. 4. JetBlue (JBLU) upgraded to Buy from Neutral at Buckingham with analyst Daniel McKenzie saying competitive capacity looks manageable at this point, but notes that his upgrade is likely "early," given IT initiatives that don't become material to revenue until the first quarter of 2020. 5. E-Trade (ETFC) and Moody's (MCO) upgraded to Buy from Neutral at UBS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/19
JPMS
07/10/19
INITIATION
Target $220
JPMS
Overweight
Moody's initiated with an Overweight at JPMorgan
JPMorgan analyst Michael Cho started Moody's with an Overweight rating and $220 price target. Despite short-term volatility from debt issuance trends, the company has displayed "impressive" organic, constant currency revenue growth driven by pricing power, innovation and a growing end markets, Cho tells investors in a research note.
MFC Manulife Financial
$17.64

0.19 (1.09%)

MUFG Mitsubishi UFJ
$4.96

0.025 (0.51%)

03/07/19
UBSW
03/07/19
UPGRADE
UBSW
Buy
Mitsubishi UFJ upgraded to Buy from Neutral at UBS
11/13/18
SBSH
11/13/18
INITIATION
SBSH
Buy
Mitsubishi UFJ initiated with a Buy at Citi
Citi analyst Koichi Niwa started Mitsubishi UFJ with a Buy rating.
NMR Nomura
$4.36

0.045 (1.04%)

07/31/19
JPMS
07/31/19
UPGRADE
JPMS
Neutral
Nomura upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Wataru Otsuka upgraded Nomura Holdings to Neutral from Underweight following the company's Q1 results.
07/31/19
JPMS
07/31/19
UPGRADE
JPMS
Neutral
Nomura upgraded to Neutral on earlier than expected progress at JPMorgan
As previously reported, JPMorgan analyst Wataru Otsuka upgraded Nomura Holdings to Neutral from Underweight following the company's Q1 results. Pretax profit rebounded sharply and topped his forecast, reported the analyst, who said the company's earnings recovery is clearer than he had expected. A shift to a more bullish rating would require further confirmation of this progress, said Otsuka, who raised his price target on Nomura shares to Y410 from Y400.
05/16/19
SBSH
05/16/19
DOWNGRADE
SBSH
Sell
Nomura downgraded to Sell from Neutral at Citi
Citigroup analyst Koichi Niwa downgraded Nomura Holdings to Sell from Neutral with a price target of 320 yen. The analyst sees a "grim" earnings environment for Nomura's domestic retail division and fixed income business. Further, Niwa believes is too optimistic that the operating environment will improve.
05/16/19
05/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Occidental Petroleum (OXY) downgraded to Hold from Buy at Argus with analyst Bill Selesky citing its confirmed purchase of Anadarko Petroleum (APC) for $76 per share and saying the company is overpaying for the assets with a bid well above that of Chevron's (CVX) $65 per share offer. 2. Nomura (NMR) downgraded to Sell from Neutral at Citi with analyst Koichi Niwa saying he sees a "grim" earnings environment for Nomura's domestic retail division and fixed income business. 3. Sito Mobile (SITO) downgraded to Hold from Buy at Lake Street with analyst Mark Argento citing the company's "big" Q1 miss and said he sees uncertainty around Sito Mobile's new product strategy and liquidity concerns in the near term. 4. The Stars Group (TSG) downgraded to Hold from Buy at Desjardins. 5. Roan Resources (ROAN) downgraded to In-Line from Outperform at Imperial Capital with analyst Irene Haas saying the company's Q1 earnings missed expectations due to well performance, ethane rejection, and weak NGL prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SCBFF Standard Chartered
$0.00

(0.00%)

07/02/19
SOCG
07/02/19
UPGRADE
SOCG
Buy
Standard Chartered upgraded to Buy from Hold at Societe Generale
SCGLY Societe Generale
$0.00

(0.00%)

08/02/19
SBSH
08/02/19
UPGRADE
SBSH
Buy
Societe Generale upgraded to Buy from Neutral at Citi
Citi analyst Azzurra Guelfi upgraded Societe Generale to Buy from Neutral with a price target of 28 euros. Progress in the company's commercial and investment banking units should drive a re-rating of the shares, Guelfi tells investors in a research note. The analyst finds Societe Generale's valuation attractive amid its turnaround.
07/16/19
JPMS
07/16/19
UPGRADE
JPMS
Overweight
Societe Generale upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Kian Abouhossein upgraded Societe Generale to Overweight and raised his price target to EUR28 from EUR27.
04/03/19
BOFA
04/03/19
INITIATION
BOFA
Underperform
Societe Generale reinstated with an Underperform at BofA/Merrill
BofA/Merrill reinstated coverage of Societe Generale with an Underperform rating. The firm has a cautious view on French banks saying the need to build up capital will take many years and that 2020 targets are "uninspiring."
10/01/19
UBSW
10/01/19
DOWNGRADE
UBSW
Neutral
Societe Generale downgraded to Neutral from Buy at UBS
UBS analyst Lorraine Quoirez downgraded Societe Generale to Neutral from Buy with a price target of 25 euros, down from 27 euros. Given the bank's lower visibility into future cash flows, a valuation to peers is warranted, Quoirez tells investors in a research note.
TW Tradeweb Markets
$41.01

1.2 (3.01%)

10/01/19
10/01/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ericsson (ERIC) upgraded to Buy from Hold at Canaccord with analyst Michael Walkley saying since the Q2 earnings report, Ericsson has announced deals with Nex-Tech, RINA, and KDDI, demonstrating continuing 5G momentum. 2. VMware (VMW) upgraded to Outperform from Market Perform at Wells Fargo with analyst Philip Winslow saying investors have been concerned that growing interest in deploying containerized applications into Kubernetes-centric environments will eventually reduce customer demand for VMware's virtualization-centric product portfolio. 3. Tradeweb Markets (TW) upgraded to Overweight from Equal Weight at Barclays with analyst Jeremy Campbell saying recent weakness in the shares "seems largely technical," which presents an "attractive upside opportunity." 4. Scotts Miracle-Gro (SMG) upgraded to Neutral from Underperform at BofA/Merrill with analyst Christopher Carey saying the bar on the company's earnings consensus may be "too low." 5. Philip Morris (PM) upgraded to Buy from Neutral at BofA/Merrill with analyst Lisa Lewandowski citing the suspended merger discussions with Altria (MO) amid the heightened risk for U.S. vaping category following reports of lung health concerns. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/01/19
LEHM
10/01/19
UPGRADE
Target $45
LEHM
Overweight
Barclays upgrades Tradeweb Markets to Overweight after pullback
Barclays analyst Jeremy Campbell upgraded Tradeweb Markets to Overweight from Equal Weight with an unchanged price target of $45. Recent weakness in the shares "seems largely technical," which presents an "attractive upside opportunity," Campbell tells investors in a research note. The analyst sees $34 per share as near-term valuation support with upside back to the low-to-mid $40's. Further, with exchange sentiment high and structural growth stories in demand, the market to absorb any forthcoming supply from the lock-up expiration, and Tradeweb has balance sheet flexibility to "buy-back some unlocked stock," says Campbell.
10/01/19
LEHM
10/01/19
UPGRADE
Target $45
LEHM
Overweight
Tradeweb Markets upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Jeremy Campbell upgraded Tradeweb Markets to Overweight from Equal Weight with a price target of $45.
09/13/19
BOFA
09/13/19
UPGRADE
BOFA
Buy
Tradeweb Markets upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Michael Carrier upgraded Tradeweb Markets to Buy from Neutral with the stock down 16% since the end of July. Meanwhile, the company's volumes continue to outperform expectations and management as shown the ability to drive revenues and margin gains relative to peers, Carrier tells investors in a research note.
UBS UBS
$10.78

0.2 (1.89%)

09/10/19
KPLR
09/10/19
UPGRADE
KPLR
Buy
UBS upgraded to Buy from Hold at Kepler Cheuvreux
08/30/19
EXAN
08/30/19
DOWNGRADE
EXAN
Neutral
UBS downgraded to Neutral from Outperform at Exane BNP Paribas
Exane BNP Paribas analyst Jeremy Sigee downgraded UBS to Neutral from Outperform and lowered his price target for the shares to 11.40 francs from 14.20 francs.
08/21/19
DZBN
08/21/19
DOWNGRADE
DZBN
Sell
UBS downgraded to Sell from Hold at DZ Bank
08/30/19
08/30/19
DOWNGRADE

Fly Intel: Top analyst downgrade
Catch up on today's top analyst downgrades with this list compiled by The Fly: 1. Ulta Beauty (ULTA) downgraded to Neutral from Buy at Citi, to Neutral from Overweight at Piper Jaffray and Atlantic Equities, to Neutral from Outperform at Exane BNP Paribas, to Market Perform from Outperform at Wells Fargo, and to Equal Weight from Overweight at Morgan Stanley. 2. Toronto-Dominion (TD) downgraded to Market Perform from Outperform at BMO Capital with analyst Sohrab Movahedi saying he views the company's Q4 results as a "low-quality meet" and believes the stock's total return potential is now in line with other similarly rated banks. 3. Novo Nordisk (NVO) downgraded to Underperform from Hold at Jefferies with analyst Peter Welford saying he believes the shares at current levels are becoming expensive. 4. UBS (UBS) downgraded to Neutral from Outperform at Exane BNP Paribas. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

PEP

PepsiCo

$136.25

-0.74 (-0.54%)

, KDP

Keurig Dr Pepper

$27.58

-0.01 (-0.04%)

07:12
10/21/19
10/21
07:12
10/21/19
07:12
Recommendations
PepsiCo, Keurig Dr Pepper analyst commentary  »

Morgan Stanley suggests…

PEP

PepsiCo

$136.25

-0.74 (-0.54%)

KDP

Keurig Dr Pepper

$27.58

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LNDC

Landec

$9.41

0.14 (1.51%)

07:11
10/21/19
10/21
07:11
10/21/19
07:11
Conference/Events
Landec management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 28

    Oct

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

LAC

Lithium Americas

$3.02

0.04 (1.34%)

07:09
10/21/19
10/21
07:09
10/21/19
07:09
Hot Stocks
Lithium Americas appoints Yuan Gao to board of directors »

Lithium Americas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$9.13

-0.17 (-1.83%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Hot Stocks
ArQule announces preclinical data showing potential for miransertib to treat VMs »

ArQule announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 30

    Oct

SON

Sonoco

$58.07

0.85 (1.49%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Upgrade
Sonoco rating change  »

Sonoco upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$130.91

-1.46 (-1.10%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Conference/Events
Disney management to meet with Oppenheimer »

Luncheon Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 07

    Nov

IDRA

Idera Pharmaceuticals

$2.68

-0.01 (-0.37%)

07:07
10/21/19
10/21
07:07
10/21/19
07:07
Hot Stocks
Idera Pharmaceuticals annnounces U.S. patent for tilsotolimod »

Idera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBI

Brickell Biotech

$4.10

-0.08 (-1.91%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Conference/Events
Brickell Biotech management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SEAS

SeaWorld

$27.88

0.23 (0.83%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
SeaWorld to open second Sesame Place theme park in San Diego in 2021 »

SeaWorld and Sesame…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMP

Armata Pharmaceuticals

$4.10

0.05 (1.23%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
Armata Pharmaceuticals announces receipt of $1.3M R&D Tax Incentive »

Armata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGTC

Applied Genetic

$3.05

-0.06 (-1.93%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
Applied Genetic presents data from non-clinical studies evaluating AAV vectors »

Applied Genetic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$236.29

0.99 (0.42%)

07:05
10/21/19
10/21
07:05
10/21/19
07:05
Recommendations
Apple analyst commentary  »

iPhone Pro lead times…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

AXLA

Axcella

$5.10

0.14 (2.82%)

07:05
10/21/19
10/21
07:05
10/21/19
07:05
Conference/Events
Axcella management to meet with SVB Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

07:05
10/21/19
10/21
07:05
10/21/19
07:05
General news
European stock markets are broadly higher »

European stock markets…

07:05
10/21/19
10/21
07:05
10/21/19
07:05
General news
FX Update: Sterling has outperformed »

FX Update: Sterling has…

AZN

AstraZeneca

$43.86

-0.25 (-0.57%)

07:04
10/21/19
10/21
07:04
10/21/19
07:04
Hot Stocks
AstraZeneca announces FDA approval of Farxiga »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 18

    Nov

  • 07

    Dec

AXSM

Axsome Therapeutics

$21.08

-1.46 (-6.48%)

07:04
10/21/19
10/21
07:04
10/21/19
07:04
Hot Stocks
Axsome Therapeutics completes patient enrollment in CONCERT Phase 2 trial »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGX

Argan

$39.36

0.82 (2.13%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Conference/Events
Argan management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ALKS

Alkermes

$18.17

0.45 (2.54%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Hot Stocks
Alkermes partners with Fred Hutchinson Cancer center to evalute ALKS 4230 »

Alkermes has entered into…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

AYTU

Aytu BioScience

$1.20

-0.04 (-3.23%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Hot Stocks
Aytu BioScience reports addition of Tuzistra XR to national PBM formulary »

Aytu BioScience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$58.91

-1.35 (-2.24%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Hot Stocks
Teradyne to acquire AutoGuide Mobile Robots for $165M »

Teradyne and AutoGuide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

BIOL

Biolase

$0.80

-0.199 (-19.90%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Earnings
Biolase sees Q3 net loss ($5.4M)-($5.8M) »

Q3 EPS consensus (13c).…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

RESN

Resonant

$2.32

-0.12 (-4.92%)

07:01
10/21/19
10/21
07:01
10/21/19
07:01
Hot Stocks
Resonant says customers shipped more than 1.5M units in Q3 »

Resonant announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

GCI

Gannett

$10.91

-0.01 (-0.09%)

, NEWM

New Media

$8.89

0.08 (0.91%)

06:59
10/21/19
10/21
06:59
10/21/19
06:59
Periodicals
Gannett, New Media deal could be in jeopardy due to regulatory glitch, NYP says »

The proposed acquisition…

GCI

Gannett

$10.91

-0.01 (-0.09%)

NEWM

New Media

$8.89

0.08 (0.91%)

APO

Apollo Global

$39.96

-0.06 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

LNG

Cheniere Energy

$62.51

0.05 (0.08%)

06:58
10/21/19
10/21
06:58
10/21/19
06:58
Initiation
Cheniere Energy initiated  »

Cheniere Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.